Meeting
2023 ASCO Annual Meeting
Epidemiologic characteristics, treatment patterns, and survival analysis of plasmablastic lymphoma in the US.
Authors
Alec Hansen
Department of Internal Medicine, University of Utah, Salt Lake City, UT
Alec Hansen , Victoria Vardell , Lindsey Fitzgerald
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 7570)
DOI
10.1200/JCO.2023.41.16_suppl.7570
Abstract #
7570
Poster Bd #
121
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer.
First Author: Jun Gong
Poster
2022 ASCO Annual Meeting
Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.
First Author: Carla Casulo
Poster
2022 ASCO Annual Meeting
Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.
First Author: Katherine E Poruk
Poster
2021 Gastrointestinal Cancers Symposium
Stage IV gastrointestinal stromal tumors: Epidemiology, treatment and outcomes in adult US patients.
First Author: Johannes Uhlig